Armistice Capital »

Moelis & Co shares owned by Armistice Capital

Quarter-by-quarter ownership of Moelis & Co (MC) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Moelis & Co

Tip: Access up to 7 years of quarterly data

All positions including Moelis & Co held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moelis & Co by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $319k 4.9k 65.42
2024-03-31 $429k 7.6k 56.77

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Moelis & Co

BlackRock
Kayne Anderson Rudnick Investment Management
Vanguard Portfolio Management
Vanguard Capital Management
Daniel D. Thurber
Charles Schwab Investment Management
Sixth Street Partners Management Company
State Street Corporation
London Company
Geode Capital Management
Ameriprise Financial
HighTower Advisors
Natixis Asset Management Advisors
Jones Financial Companies, L.L
Madison Asset Management

View all funds holding Moelis & Co